by admin | Dec 8, 2021 | Business, Funding, Healthcare, Research
Hemostatics is a spin-off company from Cima Universidad de Navarra. Hemostatics Pharmaceuticals is performing the preclinical and clinical development of the antifibrinolytic agent CM-352, a first-in-class drug that represents a pioneering therapeutic approach to...
